Health and Medical
Zootility Launches a Comfortable Face Mask
PORTLAND, Maine — Zootility, a design-driven US manufacturing company, launches a mask to provide comfort and protection to both those who are wearing masks just for a quick trip to the grocery store as well as essential workers who are masked 8+ hours per day….
Virtual Speech Therapy Company, Great Speech, Inc., Contracts with Harbour Benefits Holding Inc. to Increase Plan Participant Access to Telehealth
HOLLYWOOD, Fla. — Great Speech, Inc., a pioneer in the online speech therapy space, has contracted with Harbour Benefits Holding Inc, to increase access for much-needed virtual speech therapy services to Harbour’s plan participants….
California Plastic Surgery Practice Paves the Way for Women in Cosmetic Medicine
SACRAMENTO, Calif. — The field of plastic surgery has long had a gender imbalance: while 92% of patients are women, most plastic surgeons are men. In fact, only 1 out of 5 plastic surgeons is female. This is gradually changing, due in part to women like board certified plastic surgeon Christa Clark, MD, FACS, who employs an all-female staff at her practice, Granite Bay Cosmetic Surgery….
Rescindo Therapeutics’ RSC-57 Receives FDA Orphan Drug Designation and Rare Pediatric Disease Designation for Kabuki Syndrome
CARY, N.C. — Rescindo Therapeutics Inc., a drug discovery company dedicated to the development of new treatments for rare genetic disorders, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation and Rare Pediatric Disease Designation for the Company’s lead drug RSC-57, for the treatment of patients with Kabuki Syndrome….
JNL Technologies Launches Quantum SA Standalone Wander Management Control Unit
IXONIA, Wis. — JNL Technologies, maker of Quantum nurse call, wander management, and access control systems, is now shipping Quantum SA, a standalone wander management system. Using the same proven Bluetooth technology as JNL’s Quantum DCS product line, the Quantum SA does not require cable installation or the purchase of a Quantum server and is perfect for smaller areas that do not require centralized management….
Flightpath Biosciences Launches via Illumina Accelerator to Conduct Largest Clinical Biomarker Study in Lyme Disease
BERKELEY, Calif. — Flightpath Biosciences, a life sciences company, launched today claiming a spot in Illumina Accelerator’s second global class to develop diagnostics and microbiome-targeted therapeutics to treat rare pathogen-driven diseases. The company has operated in stealth since its founding in mid-2019 and has built a pipeline of drug candidates for a wide range of diseases, starting with acute and Persistent Lyme Disease (PLD)….
MWBE’s For PPE: American Manufacturing Re-Investing In Underserved Communities
NEW YORK, N.Y. — Minority business enterprise (MBE) New York-based development and diversity supplier firm, MRV Group, LLC partners with architectural firm DXA studio to re-invest American made PPE sales to 501(c)(6) and 501(c)(3) organizations that support MWBE’s and underserved communities impacted by COVID-19….
Kalyagen Announces Launch of ‘Stem the Tide of Time’ Campaign Featuring NBA Hall of Fame Finalist Marques Johnson
AUSTIN, Texas — Kalyagen is pleased to announce the launch of its “Stem the Tide of Time” social media campaign featuring former UCLA Bruin and Milwaukee Buck All-Star Marques Johnson to promote STEMREGEN;, a natural stem cell enhancer documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM)….
Kalyagen™ Announces Launch of Clinical Trial to Evaluate STEMREGEN® and Stem Cells for Advanced Heart Failure Patients
AUSTIN, Texas — Kalyagen™, along with the Sociedad Espanola de Medicina Regenerativa y Terapia Celular (the “Spanish Society of Regenerative Medicine and Cell Therapy”), is pleased to announce the launch of a multicenter clinical trial, “The Effect of Stemregen and Adipose Stroma Vascular Fraction (SVF) Either Individually or in Combination in Patient With Heart Failure,” to evaluate the use of stem cell therapies in patients suffering from heart failure….
EPIC Insurance Brokers & Consultants Acquires Pharmaceutical Strategies Group
SAN FRANCISCO, Calif. — EPIC Holdings, Inc. (EPIC) announced today that it has agreed to acquire Pharmaceutical Strategies Group (PSG). The move incorporates the expertise and resources of the nation’s largest independent pharmacy benefit consulting firm into EPIC’s Employee Benefits Consulting practice….